Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Dry Eye DiseaseCataract
Interventions
DRUG

Systane HYDRATION® Preservative-Free Lubricant Eye Drops

The HPG/HA group will receive Systane HYDRATION® Preservative-Free Lubricant Eye Drops and standard of care, i.e., prednisolone acetate (Pred forte®) and levofloxacin (Cravit®), at the dosage of 1-2 drops 4 times daily for 3 weeks from Weeks 1 to 4 post-op

DRUG

Optive Fusion® Lubricant Eye Drops (Unit Dose)

The CMC/HA group will receive Optive Fusion® Lubricant Eye Drops (Unit Dose) and standard of care, i.e., prednisolone acetate (Pred forte®) and levofloxacin (Cravit®), at the dosage of 1-2 drops 4 times daily for 3 weeks from Weeks 1 to 4 post-op

Trial Locations (1)

Unknown

Keelung Chang Gung Memorial Hospital, Keelung

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT06221345 - Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease | Biotech Hunter | Biotech Hunter